United States Nucleic Acid Testing Market 2025 | Exclusive Report by DatamIntelligence

"Nucleic Acid Testing market to grow at a high CAGR during the forecast period 2024-2031." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/nucleic-acid-testing-market?sp

United States: Recent Industry Developments

✅ In September 2025, Thermo Fisher Scientific launched a next-generation nucleic acid testing platform for rapid pathogen detection. The system reduces testing time while improving accuracy. It strengthens U.S. capabilities in clinical diagnostics and infectious disease monitoring.

✅ In August 2025, Abbott Laboratories invested $150 million to expand its NAT production and R&D facility in Illinois. The investment focuses on scaling high-throughput testing for hospitals and public health labs. It accelerates U.S. readiness for infectious disease outbreaks.

✅ In July 2025, Roche Diagnostics introduced an automated NAT system for point-of-care applications. The platform enables faster molecular diagnostics for respiratory and viral infections. It supports broader deployment of precision testing in U.S. healthcare.

✅ In June 2025, Hologic partnered with a biotech startup to develop CRISPR-based nucleic acid tests for rapid detection of emerging pathogens. The collaboration emphasizes speed, sensitivity, and scalability. It advances the U.S. molecular diagnostics landscape.

Japan: Recent Industry Developments

✅ In September 2025, Sysmex Corporation launched a high-sensitivity nucleic acid testing platform for hospitals and public health laboratories. The system provides faster detection of viral and bacterial pathogens. It strengthens Japan's molecular diagnostics capabilities.

✅ In August 2025, Fujirebio invested in developing rapid NAT kits for infectious disease screening, focusing on COVID-19 and influenza. The initiative aims to improve testing throughput and accuracy. It enhances Japan's public health diagnostic infrastructure.

✅ In July 2025, Tosoh Corporation introduced an automated NAT analyzer for research and clinical applications. The platform supports high-volume molecular testing and improved workflow efficiency. It contributes to Japan's advanced diagnostics ecosystem.

✅ In June 2025, Denka Company completed a pilot program for CRISPR-based nucleic acid tests for early pathogen detection. The program emphasizes rapid, scalable, and sensitive testing. It aligns with Japan's focus on next-generation diagnostic technologies.

Nucleic Acid Testing Market: Drivers

The nucleic acid testing (NAT) market is witnessing growth due to increasing demand for accurate, rapid, and sensitive detection of infectious diseases, genetic disorders, and pathogens across hospitals, diagnostic laboratories, blood banks, and research institutions. NAT enables detection of viral, bacterial, and genetic material with high specificity, supporting early diagnosis, disease monitoring, and prevention of disease transmission. Rising prevalence of infectious diseases, growing awareness of preventive healthcare, and stringent regulatory requirements for blood screening are driving adoption of NAT technologies. Technological advancements in PCR, real-time PCR, isothermal amplification, and next-generation sequencing are enhancing test sensitivity, throughput, and turnaround times. Additionally, expanding healthcare infrastructure, government initiatives, and funding for molecular diagnostics are further supporting market growth.

Innovations in multiplex testing, point-of-care NAT devices, and automated sample processing systems are enabling faster, more reliable, and scalable diagnostic solutions. Integration with digital health platforms, laboratory information management systems (LIMS), and AI-driven analytics is improving workflow efficiency, data interpretation, and clinical decision-making. The growing focus on pandemic preparedness, early detection of emerging pathogens, and personalized medicine is further boosting demand for nucleic acid testing. Collaborations between diagnostic companies, research institutions, and healthcare providers are accelerating development, commercialization, and adoption of advanced NAT solutions. Collectively, these factors are driving sustained growth in the nucleic acid testing market as healthcare systems increasingly prioritize accurate, rapid, and reliable molecular diagnostics.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/nucleic-acid-testing-market?sp

Nucleic Acid Testing Market: Major Players

Abbott Laboratories, Becton, Dickinson and Company, Beckman Coulter, Inc., Bio-Rad Laboratories, Illumina, Inc., Siemens Healthcare, bioMérieux SA, F. Hoffmann-La Roche Ltd.,, Novartis International AG, Grifols, S.A.

Segment Covered in the Nucleic Acid Testing Market:

➥ By Product Type: Nucleic Acid Test Kits, Consumables

➥ By Indication: Infectious Disease, Cancer, Forensic Testing, Genetic Disorders, Others

➥ By End-user: Hospitals, Pathology Laboratories, Research Institutes, Others

Research Process:

Both primary and secondary data sources have been used in the Nucleic Acid Testing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Nucleic Acid Testing Market Research Industry:

➠ Who leads the Nucleic Acid Testing industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Nucleic Acid Testing market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Nucleic Acid Testing market growth?
➠ What are the dominant sales and distribution strategies in the Nucleic Acid Testing industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=nucleic-acid-testing-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.